Publications We at SKC have a profound knowledge of the health care industry and want to share our valuable experience with you.
Publication Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany more
Publication Patient Reported Outcome Measures … PROM Are of Profound Importance for the Success of Health Technology Assessments in Oncologic … more
Publication The Influence of the Claimed Benefit Versus the Given Benefit on the Negotiated Rebate During the German Health Technology Assessment more
Publication When the Arbitration Office Must Decide Last Resort for Reimbursement of New Drugs in Germany more
Publication Repurposed Drugs Launched Under the … Effects on Benefit Assessment and Price Development more
Publication Is No Therapy a Therapy? Effects of Watchful Waiting as Appropriate Comparator Therapy for New Drugs on Benefit Assessment … more
Publication From Vague to Valid Chances and Risks of Benefit Re-Assessments Due to New Scientific Evidence in Germany more
Publication Does Size Matter? Impact of Population Size on Evidence Quality and Negotiation Outcome for Orphan Drugs in Germany more
Strategy Report Act: Financial Stabilization of the SHI Strategic implications for market access in Germany more
Strategy Report Routine practice data collection for … Lessons learned from 2 years - Risk factors and strategic … more
Strategy Report The value of a digital operating room Lessons learned for a future-proof digitization approach in … more
Strategy Report Whitepaper: Registry requirements for … The G-BA specifies the procedure on the post-launch data … more
Strategy Report Successful market access for gene … New strategic challenges and possible solutions more
